Avexitide
45 trials in this molecule. Source: ClinicalTrials.gov, as of July 6, 2026.
Trials
45
Ongoing
8
Recruiting
5
Completed
31
Sites
55
Countries
6
Endpoints
0
Composite endpoints
0
Distinct sites and countries across this molecule's trials. A site running several of its trials counts once, matching the map.
Where the program stands
Trials by phase
Early Phase 1
6
Phase 1
10
Phase 1/2
2
Phase 2
8
Phase 3
4
Phase 4
2
Not applicable
13
Trials by status
Not yet recruiting
2
Recruiting
5
Active, not recruiting
1
Completed
31
Terminated
1
Withdrawn
2
Unknown
3
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Top 20 metrics across this asset's endpoints
Programs for this asset
Every trial for this molecule, with the same search, filters, and sort as the Trials tab.
⌘K
45 of 45
Showing 1-25 of 45 trials